Topics

FDA clears IND for VistaGen's Parkinson's drug

06:41 EST 31 Jan 2020 | SmartBrief

VistaGen Therapeutics' investigational new drug application for its N-methyl-D-aspartate receptor glycine site antagonist can -More

Original Article: FDA clears IND for VistaGen's Parkinson's drug

NEXT ARTICLE

More From BioPortfolio on "FDA clears IND for VistaGen's Parkinson's drug"

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...